Concepedia

Steven T. Dock

ST

Statistics

Publications

3

Citations

178

H-Index

3

Active since

2010

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Steven T. Dock is an author at GlaxoSmithKline (United States) specializing in pharmacotherapy, drug discovery, and medicine.

Top concepts

Publications per year

2010–2017

3

Publications

3

Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120)

Steven M. Sparks, Grace Chen, Jon L. Collins et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 102 citations · Full text

, , +6

Synthesis and SAR of Benzisothiazole- and Indolizine-β-<scp>d</scp>-glucopyranoside Inhibitors of SGLT2

Huiqiang Zhou, Dana P. Danger, Steven T. Dock et al. · ACS Medicinal Chemistry Letters · 2010 · 51 citations · Full text

Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist

Steven M. Sparks, Christopher Aquino, Pierette Banker et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 25 citations · Full text

, , +7

1–3 of 3